Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CODX Co-diagnostics Inc.

Trading 12-09 15:10:52 EST

0.3679

+0.0210

+6.05%

High0.3700	Low0.3444	Vol1.14M
Open0.3592	D1 Closing0.3469	Amplitude7.38%
Mkt Cap22.40M	Tradable Cap16.74M	Total Shares60.89M
T/O409.04K	T/O Rate2.50%	Tradable Shares45.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CODX","market":"US","secType":"STK","nameCN":"Co-diagnostics Inc.","latestPrice":0.3679,"timestamp":1765311049129,"preClose":0.3469,"halted":0,"volume":1139717,"delay":0,"floatShares":45509000,"shares":60892582,"eps":-0.966925,"marketStatus":"Trading","change":0.021,"latestTime":"12-09 15:10:52 EST","open":0.3592,"high":0.37,"low":0.3444,"amount":409042.74451884,"amplitude":0.073796,"askPrice":0.3698,"askSize":189,"bidPrice":0.3674,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.966925,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765314000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.3469,"preHourTrading":{"tag":"盘前","latestPrice":0.3582,"preClose":0.3469,"latestTime":"09:29 EST","volume":8432,"amount":2964.12144976,"timestamp":1765290568501},"postHourTrading":{"tag":"盘后","latestPrice":0.345,"preClose":0.3469,"latestTime":"19:59 EST","volume":15372,"amount":5322.0416,"timestamp":1765241968336},"volumeRatio":0.897517,"impliedVol":1.6193,"impliedVolPercentile":0.62},"requestUrl":"/m/hq/s/CODX","defaultTab":"news","newsList":[{"id":"2590344591","title":"Co-Diagnostics Unveils Portable Cloud-Connected PCR Platform at Boston Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2590344591","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590344591?lang=en_us&edition=fundamental","pubTime":"2025-12-09 22:02","pubTimestamp":1765288925,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. presented at the Point-of-Care Testing 2025 Exhibition and Conference in Boston, Massachusetts. The company delivered a session titled \"Exploring the Promise of Portable, Cloud-Connected PCR Diagnostics,\" which highlighted their move toward portable PCR diagnostics for point-of-care needs. The presentation introduced the upcoming Co-Dx PCR platform and its smartphone interface, and discussed the integration of AI to minimize user error and enhance real-time testing outcomes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on December 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL3kmW8p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2590435708","title":"CoSara Diagnostics to Showcase New PCR Tests at VIROCON 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2590435708","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590435708?lang=en_us&edition=fundamental","pubTime":"2025-12-09 01:37","pubTimestamp":1765215451,"startTime":"0","endTime":"0","summary":"CoSara, Co-Diagnostics Inc. Affiliate, to Showcase TB and HPV PCR Tests at VIROCON 2025 in Pune. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL28CtfY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2589810989","title":"Co-Diagnostics Inc. held shareholder meeting on reverse stock split proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2589810989","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589810989?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:31","pubTimestamp":1764970294,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. held a special meeting of shareholders on December 5, 2025. Shareholders approved an amendment to the Articles of Incorporation to authorize a reverse stock split of the company's issued and outstanding shares of common stock, at a ratio to be determined by the Board within twelve months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL8MqhmG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2586250959","title":"Co-Diagnostics Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250959","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250959?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:55","pubTimestamp":1764165300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CODX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 26, 2025 08:55 ET (13:55 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2586254101","title":"Co-Diagnostics Inc : Maxim Group Initiates Coverage With Buy Rating; Target Price $1.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2586254101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586254101?lang=en_us&edition=fundamental","pubTime":"2025-11-26 20:36","pubTimestamp":1764160599,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20GK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2585627469","title":"Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX), Stevanato Group (STVN) and Alpha Cognition Inc (ACOG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585627469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585627469?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:30","pubTimestamp":1763983822,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Co-Diagnostics (CODX – Research Report), Stevanato Group (STVN – ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-co-diagnostics-codx-stevanato-group-stvn-and-alpha-cognition-inc-acog-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-co-diagnostics-codx-stevanato-group-stvn-and-alpha-cognition-inc-acog-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4568","LU0029874061.USD","XBI","BK4137","BK4585","BK4082","HCSG","LABU","LU0128526141.USD","STVN","XLV","BK4139","CODX","ACOG","BK4581","BK4121","BK4539"],"gpt_icon":0},{"id":"2584137522","title":"Co-Diagnostics Addresses Tuberculosis Test Adoption at The Union World Conference on Lung Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2584137522","media":"Reuters","labels":["corporation","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584137522?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:01","pubTimestamp":1763647306,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc., a molecular diagnostics company, participated in the 2025 International Union Against Tuberculosis and Lung Disease  World Conference on Lung Health in Copenhagen, Denmark. During a satellite session, Executive Vice President of Business Development Joseph Featherstone delivered a talk on the adoption and implementation of a new tuberculosis molecular diagnostic test. The company announced plans to begin clinical performance testing of the new test soon, with a focus on addressing testing needs in India and South Africa. Co-Diagnostics also highlighted recent developments, including a proprietary sample preparation instrument for point-of-care testing and ongoing exploration of a strategic transaction for its Indian joint venture, CoSara Diagnostics Pvt. Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL5lgSsn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2584755927","title":"Co-Diagnostics Initiates Clinical Evaluations For Upper Respiratory Multiplex Point-Of-Care Test On Co-Dx™ Pcr Platform To Support Submission To The U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2584755927","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584755927?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:58","pubTimestamp":1763575094,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc ::*CO-DIAGNOSTICS INITIATES CLINICAL EVALUATIONS FOR UPPER RESPIRATORY MULTIPLEX POINT-OF-CARE TEST ON CO-DX PCR PLATFORM TO SUPPORT SUBMISSION TO THE U.S. FDA  ((Reuters Investor B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD8H2KD6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2584695389","title":"Co-Diagnostics Launches Clinical Trials for Multiplex PCR Respiratory Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2584695389","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584695389?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:01","pubTimestamp":1763474470,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. has announced the initiation of clinical evaluations for its Co-Dx PCR Flu A/B, COVID-19, RSV Test Kit on the Co-Dx PCR Pro instrument. The company stated that the clinical performance testing is expected to support a submission to the U.S. Food and Drug Administration for 510 clearance. Results of the clinical testing may also be used to support submissions to other regulatory authorities, including the Saudi Food and Drug Authority. No results from the clinical study have been presented yet. The Co-Dx PCR Flu A/B, COVID-19, RSV Test Kit is designed for the simultaneous detection and differentiation of influenza A, influenza B, COVID-19, and RSV at or near the point of care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDLbdKlwc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2584958027","title":"Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ Pcr Platform to Support Submission to the U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2584958027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584958027?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:00","pubTimestamp":1763474408,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA7Z9BVH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2583514354","title":"Co-Diagnostics Raises $3.8 Million in Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514354","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514354?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:08","pubTimestamp":1763068104,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. announced the closing of a Registered Direct Offering  with gross proceeds of approximately $3.8 million before deducting offering expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL4NGj2y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2583511425","title":"Co-Diagnostics reports Q3 net loss of $5.9 million on $11.4 million in cash and securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511425","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511425?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:04","pubTimestamp":1763067892,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. reported third quarter 2025 financial results with operating expenses of approximately $7.1 million, a decrease of 32.6% year-over-year. The company recorded an operating loss of $7.0 million, compared to $10.2 million in the same period last year, and a net loss of $5.9 million, or $0.16 per fully diluted share, versus a net loss of $9.7 million, or $0.32 per fully diluted share, in third quarter 2024. Adjusted EBITDA loss was $6.3 million. Cash, cash equivalents, and marketable securities totaled $11.4 million as of September 30, 2025. Business developments included the closing of a Registered Direct Offering with gross proceeds of $3.8 million, the signing of a definitive agreement for a joint venture in Saudi Arabia and 18 MENA markets, and the formation of a new artificial intelligence business unit. The company also developed a proprietary sample preparation instrument for its tuberculosis test and performed in-silico analysis confirming the effectiveness of i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL1wPW5X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2583199511","title":"Co-Diagnostics Launches Joint Venture with Arabian Eagle Manufacturing for MENA Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2583199511","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583199511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:02","pubTimestamp":1763067739,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. has entered into a definitive agreement with Arabian Eagle Manufacturing to research, develop, manufacture, assemble, distribute, and commercialize Co-Dx technologies and intellectual property in the Kingdom of Saudi Arabia  and 18 other MENA nations. This partnership will operate through the newly formed joint venture, CoMira Diagnostics, fulfilling the objectives of a memorandum of understanding signed in September 2025. The collaboration aims to establish a strong commercial presence for Co-Diagnostics in the region, supporting the localization of advanced molecular diagnostics in one of the world's fastest-growing healthcare markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL1fxKD6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2583161511","title":"BRIEF-Co-Diagnostics Q3 Revenue USD 100 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2583161511","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583161511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:01","pubTimestamp":1763067706,"startTime":"0","endTime":"0","summary":"BRIEF-Co-Diagnostics Q3 Revenue USD 100 Thousand\n\n\nNov 13 (Reuters) - Co-Diagnostics Q3 net income USD -5.9 million.\n\nQ3 operating income USD -7 million\nQ3 operating expenses USD 7.1 million\nQ3 adjusted EBITDA USD -6.3 million\nQ3 EPS USD -0.16","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXBE7255:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2583698511","title":"Co-Diagnostics Q3 Adjusted Ebitda USD -6.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583698511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583698511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:01","pubTimestamp":1763067661,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXBE7255:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2583511905","title":"Press Release: Co-Diagnostics Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511905","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511905?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:01","pubTimestamp":1763067660,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its financial results for the third quarter ended September 30, 2025.-- Performed in-silico analysis of the primer sets used in its. Co-Primers-based PCR tests for the detection of chikungunya virus. , showing high homology against over 1,200 CHIKV sequences and. confirming reactivity of CHIKV primers against known recent strains of. -- Company closed on a Registered Direct Offering  with gross proceeds. of approximately $3.8 million before deducting offering expenses. -- Signed definitive agreement with Arabian Eagle Manufacturing to research,technologies and intellectual property in KSA and 18 MENA nations through. the JV CoMira Diagnostics, fulfilling the objective of the MOU signed in. business unit led by Chief Technology & AI Officer Christopher Thurston,to integrate the Company's ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","CODX","R","BK4099","BK4211","BK4604","BK4585","MTB","LU0106831901.USD","LU0053666078.USD","BK4588","BK4232","BK4082","BK4555","BK4022","LU0170899867.USD","LU0738911758.USD","LU0661504455.SGD","TM","BK4568","LU0949170772.SGD","03160"],"gpt_icon":0},{"id":"2582372936","title":"Co-Diagnostics Forms Joint Venture in Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2582372936","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582372936?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:01","pubTimestamp":1762956080,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc., a Utah-based diagnostics company, has announced the formation of CoMira Diagnostics, a joint venture in the Kingdom of Saudi Arabia. The agreement highlights Co-Diagnostics' expanding presence in the Middle East and North Africa region. The partnership was recognized by Utah Governor Spencer Cox and BioUtah, who praised the company for representing Utah's rapidly growing life sciences sector on the global stage.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on November 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLGWbh4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2581777324","title":"BRIEF-Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777324","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581777324?lang=en_us&edition=fundamental","pubTime":"2025-11-05 22:04","pubTimestamp":1762351482,"startTime":"0","endTime":"0","summary":"BRIEF-Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Nov 5 (Reuters) - Co-Diagnostics Inc CODX.O:CO-DIAGNOSTICS ENGAGES MAXIM GROUP TO P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WH1CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2581773450","title":"Co-Diagnostics Engages Maxim Group to Explore Strategic Options for CoSara Joint Venture","url":"https://stock-news.laohu8.com/highlight/detail?id=2581773450","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581773450?lang=en_us&edition=fundamental","pubTime":"2025-11-05 22:01","pubTimestamp":1762351303,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. has engaged Maxim Group LLC as its exclusive financial advisor to explore strategic alternatives for its Indian joint venture, CoSara Diagnostics Pvt. Ltd. Options under consideration include a potential merger with a Special Purpose Acquisition Company  or a similar entity listed on a U.S. national securities exchange. CoSara, established in 2017 as a joint venture between Co-Diagnostics and Synbiotics Ltd., manufactures and sells molecular diagnostics products, with an initial focus on the Indian market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on November 05, 2025, and is solely responsible for the informati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL9md2Pk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2581731427","title":"Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for Its Indian Joint Venture, Cosara Diagnostics Pvt. Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2581731427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581731427?lang=en_us&edition=fundamental","pubTime":"2025-11-05 22:00","pubTimestamp":1762351250,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WH1CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4568","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.codiagnostics.com","stockEarnings":[{"period":"1week","weight":-0.0401},{"period":"1month","weight":-0.1458},{"period":"3month","weight":0.1041},{"period":"6month","weight":0.1759},{"period":"1year","weight":-0.5924},{"period":"ytd","weight":-0.5375}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":0.0189},{"period":"3month","weight":0.0512},{"period":"6month","weight":0.1368},{"period":"1year","weight":0.1247},{"period":"ytd","weight":0.1664}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.381937},{"month":2,"riseRate":0.25,"avgChangeRate":0.238781},{"month":3,"riseRate":0.25,"avgChangeRate":-0.177692},{"month":4,"riseRate":0.375,"avgChangeRate":0.008039},{"month":5,"riseRate":0.375,"avgChangeRate":0.046537},{"month":6,"riseRate":1,"avgChangeRate":0.106921},{"month":7,"riseRate":0.625,"avgChangeRate":0.172835},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.06719},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.02377},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.003584},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.082815},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.143508}],"exchange":"NASDAQ","name":"Co-diagnostics Inc.","nameEN":"Co-diagnostics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Co-diagnostics Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Co-diagnostics Inc.,CODX,Co-diagnostics Inc.股票,Co-diagnostics Inc.股票老虎,Co-diagnostics Inc.股票老虎国际,Co-diagnostics Inc.行情,Co-diagnostics Inc.股票行情,Co-diagnostics Inc.股价,Co-diagnostics Inc.股市,Co-diagnostics Inc.股票价格,Co-diagnostics Inc.股票交易,Co-diagnostics Inc.股票购买,Co-diagnostics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Co-diagnostics Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction